Sean Maduck Corcept Therapeutics Inc (CORT) insider trading activity

Sean Maduck is of CORCEPT THERAPEUTICS INC. Currently has a direct ownership of 85,318 shares of CORT, which is worth approximately $4.59 Million. The most recent transaction as insider was on Nov 01, 2023, when has been sold 5,112 shares (Common Stock) at a price of $28.08 per share, resulting in proceeds of $143,544. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 85.3K

1.37% 3M change

16.41% 12M change

Total Value Held $4.59 Million

Sean Maduck Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 01 2023	SELL Open market or private sale	$143,544 $28.08 p/Share	5,112 Reduced 6.52%	73,291 Common Stock
Nov 01 2023	BUY Exercise of conversion of derivative security	$13,342 $2.61 p/Share	5,112 Added 6.12%	78,403 Common Stock
Oct 10 2023	SELL Open market or private sale	$504,073 $27.29 p/Share	18,471 Reduced 20.13%	73,291 Common Stock
Oct 10 2023	BUY Exercise of conversion of derivative security	$52,088 $2.82 p/Share	18,471 Added 16.71%	92,081 Common Stock
Oct 06 2023	SELL Open market or private sale	$95,285 $27.24 p/Share	3,498 Reduced 4.54%	73,610 Common Stock
Oct 06 2023	BUY Exercise of conversion of derivative security	$10,563 $3.02 p/Share	3,498 Added 4.34%	77,108 Common Stock
Oct 02 2023	SELL Open market or private sale	$82,564 $27.24 p/Share	3,031 Reduced 3.95%	73,610 Common Stock
Oct 02 2023	BUY Exercise of conversion of derivative security	$9,153 $3.02 p/Share	3,031 Added 3.8%	76,641 Common Stock
Sep 19 2023	SELL Open market or private sale	$811,999 $32.48 p/Share	25,000 Reduced 25.35%	73,610 Common Stock
Sep 18 2023	BUY Exercise of conversion of derivative security	$75,500 $3.02 p/Share	25,000 Added 20.22%	98,610 Common Stock
Sep 01 2023	BUY Grant, award, or other acquisition	$15,093 $16.55 p/Share	912 Added 1.22%	73,610 Common Stock
Jul 17 2023	BUY Exercise of conversion of derivative security	$19,200 $1.92 p/Share	10,000 Added 12.09%	72,698 Common Stock
Jun 01 2023	BUY Grant, award, or other acquisition	$38,100 $11.49 p/Share	3,316 Added 5.02%	62,698 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	$28,995 $9.93 p/Share	2,920 Added 4.69%	59,382 Common Stock
Dec 01 2022	SELL Open market or private sale	$15,800 $25.28 p/Share	625 Reduced 1.09%	56,462 Common Stock
Dec 01 2022	BUY Exercise of conversion of derivative security	$2,056 $3.29 p/Share	625 Added 1.08%	57,087 Common Stock
Nov 10 2022	SELL Open market or private sale	$639,250 $25.57 p/Share	25,000 Reduced 30.69%	56,462 Common Stock
Nov 10 2022	BUY Exercise of conversion of derivative security	$82,250 $3.29 p/Share	25,000 Added 23.48%	81,462 Common Stock
Oct 03 2022	SELL Open market or private sale	$641,000 $25.64 p/Share	25,000 Reduced 30.69%	56,462 Common Stock
Oct 03 2022	BUY Exercise of conversion of derivative security	$82,250 $3.29 p/Share	25,000 Added 23.48%	81,462 Common Stock
Sep 01 2022	SELL Open market or private sale	$646,000 $25.84 p/Share	25,000 Reduced 31.4%	54,618 Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	$82,250 $3.29 p/Share	25,000 Added 23.9%	79,618 Common Stock
Sep 01 2022	BUY Grant, award, or other acquisition	$23,954 $12.99 p/Share	1,844 Added 3.16%	56,462 Common Stock
Aug 19 2022	SELL Payment of exercise price or tax liability	$11,206 $27.6 p/Share	406 Reduced 0.74%	54,618 Common Stock
Aug 19 2022	BUY Exercise of conversion of derivative security	$33,600 $2.24 p/Share	15,000 Added 21.42%	55,024 Common Stock

Sean Maduck

Menlo Park, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CORT shares.

Notify only if

Value

Insider Trading

Get notified when an Corcept Therapeutics Inc insider buys or sells CORT shares.

Notify only if

Operation

Value

Type

News

Receive news related to CORCEPT THERAPEUTICS INC

Track Activities on CORT

Account